6315-55-5

Usage

Uses

Used in Pharmaceutical Research:
1-thien-2-ylpropan-1-amine is used as a research compound for its potential biological activities, which can contribute to the development of new drugs and therapies.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-thien-2-ylpropan-1-amine is utilized as a building block for designing and synthesizing novel pharmaceutical agents with specific therapeutic targets.
Used in Organic Synthesis:
1-thien-2-ylpropan-1-amine serves as a precursor in organic synthesis, enabling the creation of other compounds with tailored properties for various applications.
Used in Drug Development:
Due to its structural features, 1-thien-2-ylpropan-1-amine is of interest in the development of new drugs, potentially leading to the discovery of innovative treatments for various diseases and conditions.

InChI:InChI=1/C7H11NS/c1-2-6(8)7-4-3-5-9-7/h3-6H,2,8H2,1H3

Upstream product

• 13679-75-9 1-thiophen-2-yl-propan-1-one 
• 77287-34-4 formamide 
• 39204-57-4 2-(1-formylaminopropyl)-thiophene 

Downstream Products

• 473726-99-7 C₂₀H₂₁N₃O₄S 

Relevant academic research and scientific papers

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides

The invention relates to novel substituted 2,4-diamino-1,3,5-triazines of the formula (I) in which R1represents, for exampe, H or C1-C6-alkyl, R2represents, for example, H, C1-C6-alkyl or —CO—R6, R3represents, for example, H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl or C3-C6-cycloalkyl, R4represents, for example, H, C1-C6-alkyl or C3-C6-cycloalkyl, R5represents one of the groupings below, where R6represents, for example, C1-C6-alkyl, C1-C6-alkoxy or C2-C6-alkenyl, R7to R12represents, for example, H or certain organic radicals and Q represents O or S, to processes and novel intermediates for their preparation and to their use as herbicides.